927 results on '"Mizutani, Shuki"'
Search Results
2. PAX3/7-FOXO1 fusion-negative alveolar rhabdomyosarcoma in Schuurs-Hoeijmakers syndrome
3. Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia
4. Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases
5. Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome
6. Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type
7. Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients
8. Placenta mediates the effect of maternal hypertension polygenic score on offspring birth weight: a study of birth cohort with fetal growth velocity data
9. Ataxia–telangiectasia
10. List of contributors
11. Personalized pharmacokinetic targeting with busulfan in allogeneic hematopoietic stem cell transplantation in infants with acute lymphoblastic leukemia
12. Detection of ATM Gene Mutation in Human Glioma Cell Line M059J by a Rapid Frameshift/Stop Codon Assay in Yeast
13. Cytoplasmic p21 Cip1/ WAF1 Regulates Neurite Remodeling by Inhibiting Rho-Kinase Activity
14. Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF–positive leukemic cells
15. Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol
16. Supplementary Figure 5 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA
17. Data from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA
18. Supplementary Figure 3 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA
19. Supplementary Figure 2 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA
20. Supplementary Figure 1 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA
21. Supplementary Figure 6 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA
22. Supplementary Figure 4 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA
23. Supplementary Figure Legends 1-5 from ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA
24. Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia
25. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor
26. Identification of CD34’ and CD34− leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia
27. Current methods of preventing infectious disease and managing febrile neutropenia in childhood cancer patients: a nationwide survey in Japan
28. The DNA damage response pathway in normal hematopoiesis and malignancies
29. HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy
30. A new microcolumn-type microchip for examining the expression of chimeric fusion genes using a nucleic acid sandwich hybridization technique
31. Flow cytometric analysis as an additional predictive tool of treatment response in children with chronic‐phase chronic myeloid leukemia treated with imatinib
32. Molecular and Virological Evidence of Viral Activation From Chromosomally Integrated Human Herpesvirus 6A in a Patient With X-Linked Severe Combined Immunodeficiency
33. Fludarabine, cytarabine, granulocyte colony‐stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia
34. First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors
35. Polymerase Chain Reaction Studies on Chronic Myelogenous Leukemias and Detection of Residual Ph1 Clone after Bone Marrow Transplantation
36. Mutations in Bruton’s tyrosine kinase impair IgA responses
37. Process for immune defect and chromosomal translocation during early thymocyte development lacking ATM
38. Graft versus host disease-dependent renal dysfunction after hematopoietic stem cell transplantation
39. Immunologically Silent Cancer Clone Transmission from Mother to Offspring
40. Hematopoietic myeloid cell differentiation diminishes nucleotide excision repair
41. Effect of eculizumab and recombinant human soluble thrombomodulin combination therapy in a 7-year-old girl with atypical hemolytic uremic syndrome due to anti-factor H autoantibodies
42. Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group
43. Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experience
44. Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
45. Ataxia-Telangiectasia
46. Application of the Nutrient-Rich Food Index 9.3 and the Dietary Inflammatory Index for Assessing Maternal Dietary Quality in Japan: A Single-Center Birth Cohort Study
47. PAX3/7-FOXO1 fusion-negative alveolar rhabdomyosarcoma in Schuurs-Hoeijmakers syndrome
48. DNA damage response and disorders with hematology, oncology and immunology
49. Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero
50. Transient abnormal myelopoiesis in non-Down syndrome neonate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.